Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kine Eide Kvitne"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 7, p 855 (2024)
The evaluation of transporter-mediated drug–drug interactions (DDIs) during drug development and post-approval contributes to benefit–risk assessment and helps formulate clinical management strategies. The use of endogenous biomarkers, which are
Externí odkaz:
https://doaj.org/article/7cb18cf515ea4c15b52a3e04238439de
Autor:
Kine Eide Kvitne, Anders Åsberg, Line K. Johnson, Christine Wegler, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Rune Sandbu, Eva Skovlund, Hege Christensen, Rasmus Jansson‐Löfmark, Jøran Hjelmesæth, Ida Robertsen
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 11, Pp 2685-2696 (2022)
Abstract Previous studies have not accounted for the close link between type 2 diabetes mellitus (T2DM) and obesity when investigating the impact of T2DM on cytochrome P450 (CYP) activities. The aim was to investigate the effect of T2DM on in vivo ac
Externí odkaz:
https://doaj.org/article/1f0c72378b57453fa0275240cbd18d14
Autor:
Kine Eide Kvitne, Ida Robertsen, Eva Skovlund, Hege Christensen, Veronica Krogstad, Christine Wegler, Philip Carlo Angeles, Birgit Malene Wollmann, Kristine Hole, Line Kristin Johnson, Rune Sandbu, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Jøran Hjelmesæth, Rasmus Jansson‐Löfmark, Anders Åsberg
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 221-233 (2022)
Abstract It remains uncertain whether pharmacokinetic changes following Roux‐en‐Y gastric bypass (RYGB) can be attributed to surgery‐induced gastrointestinal alterations per se and/or the subsequent weight loss. The aim was to compare short‐
Externí odkaz:
https://doaj.org/article/94c01bed522b40c5b3bb33a9c5738373
Autor:
Kine Eide Kvitne, Ole Martin Drevland, Nora Haugli, Eline Skadberg, Hasse Khiabani Zaré, Anders Åsberg, Ida Robertsen
Publikováno v:
Clinical Pharmacokinetics.
Autor:
Kine Eide Kvitne, Kristine Hole, Veronica Krogstad, Birgit Malene Wollmann, Christine Wegler, Line K. Johnson, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Rune Sandbu, Jøran Hjelmesæth, Eva Skovlund, Hege Christensen, Rasmus Jansson-Löfmark, Anders Åsberg, Espen Molden, Ida Robertsen
Publikováno v:
European Journal of Clinical Pharmacology
1289–1299
1289–1299
Purpose Variability in cytochrome P450 3A4 (CYP3A4) metabolism is mainly caused by non-genetic factors, hence providing a need for accurate phenotype biomarkers. Although 4β-hydroxycholesterol (4βOHC) is a promising endogenous CYP3A4 biomarker, add
Autor:
Markus Hovd, Ida Robertsen, Line Kristin Johnson, Veronica Krogstad, Christine Wegler, Kine Eide Kvitne, Marianne Kristiansen Kringen, Eva Skovlund, Cecilia Karlsson, Shalini Andersson, Per Artursson, Rune Sandbu, Jøran Hjelmesæth, Anders Åsberg, Rasmus Jansson-Löfmark, Hege Christensen
Publikováno v:
Clinical Pharmacokinetics
Introduction Rosuvastatin pharmacokinetics is mainly dependent on the activity of hepatic uptake transporter OATP1B1. In this study, we aimed to investigate and disentangle the effect of Roux-en-Y gastric bypass (RYGB) and weight loss on oral clearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a71b5f7a1e75507663c485c5c524a8
http://hdl.handle.net/10852/102727
http://hdl.handle.net/10852/102727
Publikováno v:
European Journal of Clinical Pharmacology. 78:1865-1866
Autor:
Kine Eide Kvitne, Veronica Krogstad, Christine Wegler, Line Kristin Johnson, Marianne K. Kringen, Markus Herberg Hovd, Jens K. Hertel, Maria Heijer, Rune Sandbu, Eva Skovlund, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Jøran Hjelmesæth, Anders Åsberg, Rasmus Jansson‐Löfmark, Hege Christensen, Ida Robertsen
Publikováno v:
British Journal of Clinical Pharmacology
Aim: Roux-en-Y gastric bypass (RYGB) may influence drug disposition due to surgery-induced gastrointestinal alterations and/or subsequent weight loss. The objective was to compare short- and long-term effects of RYGB and diet on the metabolic ratios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0241f6f84f9cf1970dd8533e1d69f15
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-495117
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-495117
Autor:
Hege Christensen, Veronica Krogstad, Philip Carlo Angeles, Anders Åsberg, Ida Robertsen, Kine Eide Kvitne, Rasmus Jansson-Löfmark, Kristine Hole, Per Artursson, Rune Sandbu, Shalini Andersson, Christine Wegler, Line Kristin Johnson, Birgit M Wollmann, Jøran Hjelmesæth, Eva Skovlund, Tommy B. Andersson, Cecilia Karlsson
Publikováno v:
Clinical and Translational Science (CTS)
Clinical and Translational Science
Clinical and Translational Science, Vol 15, Iss 1, Pp 221-233 (2022)
Clinical and Translational Science
Clinical and Translational Science, Vol 15, Iss 1, Pp 221-233 (2022)
It remains uncertain whether pharmacokinetic changes following Roux‐en‐Y gastric bypass (RYGB) can be attributed to surgery‐induced gastrointestinal alterations per se and/or the subsequent weight loss. The aim was to compare short‐ and long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62809665bead3028aaa50ba4bebae32d
https://hdl.handle.net/11250/2824429
https://hdl.handle.net/11250/2824429
Autor:
Jan Brox, Jens Bollerslev, Ida Robertsen, Karsten Midtvedt, Anders Hartmann, Kine Eide Kvitne, Thea Anine Strøm Halden, Laavanyaah Rajakumar, Trond Jenssen, Anders Åsberg
OBJECTIVE Sodium–glucose cotransporter 2 (SGLT2) inhibitors have lately become the recommended treatment in patients with type 2 diabetes and high cardiovascular risk. Patients with posttransplant diabetes mellitus (PTDM) also have high cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a198c9b83c269e9af569b41afc880062
http://hdl.handle.net/10852/76332
http://hdl.handle.net/10852/76332